PUK Ventures

PUK Ventures is the venture capital arm of Partnerships UK plc. It operate a £25m fund, investing in businesses with UK public sector sponsorship and strong commercial potential. Objective is enhance the value of assets, including technology and IP, created in UK public bodies such as universities and public sector research labs.

Elaine Loukes

Elaine Loukes Investment Director

5 past transactions

Monica Healthcare

Venture Round in 2009
Monica Healthcare specializes in the manufacturing and supply of advanced fetal monitoring devices aimed at improving obstetric care for midwives, labor and delivery nurses, and expectant mothers. The company’s flagship product, The Novii, is a single-use wireless patch system that monitors maternal heart rate, fetal heart rate, and uterine activity, enhancing the birthing experience. Additionally, Monica Healthcare develops a range of wearable devices that utilize innovative wireless technologies to provide accessible obstetric services both in hospitals and at home. The company also offers training, repairs, and support services for its products. Established in 2005 and headquartered in Nottingham, United Kingdom, with a location in Kennesaw, Georgia, Monica Healthcare operates as a subsidiary of GE Healthcare.

Cascade Technologies

Venture Round in 2008
Cascade Technologies offers a number of products that allow for monitoring of greenhouse and general industrial emissions, hazardous gases, explosives and drugs.

NuTech Solutions

Series B in 2007
NuTech Solutions was founded in 1999 upon the cutting-edge work of several world-renowned scientists with a mission to develop truly dynamic technology solutions that could not only predict what's coming next, but intelligently learn and adapt.

NiTech Solutions

Venture Round in 2007
NiTech Solutions is a authority on delivering step-change process improvement benefits through the use of baffled reactor technology. NiTech’s innovative team have a diverse range of skillsets including process design, chemistry, chemical engineering, reaction engineering and biotechnology/pharma. We have experience, expertise and know-how in successfully transferring existing batch to continuous processes using our technology, together with the development of new innovative processes.

CellTran

Venture Round in 2007
CellTran Limited engages in the research and development of products for the regeneration of tissue and the healing of wounds. The company offers Myskin that is used for the treatment of difficult to heal wounds; Lyphoderm, a freeze-dried lysate from cultured human keratinocytes that is formulated into a hydrophilic gel; and Ulcodress, an integrated wound care dressing that provides control of moisture, infection, and proteases within the wound area. It provides skin banking services, as well as contract manufacture services in the fields of materials fabrication and cell culture. The company was founded in 2000 and is based in Sheffield, the United Kingdom. As of October 28, 2008, CellTran Limited operates as a subsidiary of York Pharma plc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.